Overexpression of LI-cadherin in gastric cancer is associated with lymph node metastasis
Section snippets
Materials and methods
Patients and specimens. Seventy-one pairs of tumor and non-cancerous gastric mucosa were obtained from patients who underwent gastrectomy for histologically proven gastric adenocarcinoma at the University of Hong Kong Medical Center, Queen Mary Hospital, from October 2001 to April 2003. Metastatic lymph nodes were also harvested during gastrectomy. Immediately after removal, the tissues were split into two parts, one snap-frozen in liquid nitrogen and stored at −80 °C until use, and the other
Clinicopathological data (Table 1)
There was a slight male predominance. The majority of tumors were located in the distal stomach (65%) and of intestinal type (61%) according to Lauren’s classification [9]. The tumors were staged according to the criteria of the Japanese Research Society for Gastric Cancer [10]. Most patients presented late with advanced diseases as evidenced by their advanced stages and high incidence of lymph node metastasis (Table 1).
Over-expression of LI-cadherin mRNA
LI-cadherin was absent in half of the non-cancerous mucosal specimens but
Discussion
The exact mechanism responsible for the development of gastric cancer is still unclear. A number of studies have shown that the development of gastric cancer is a multi-step process that involves changes in multiple genes including tumor suppressor genes, oncogenes, cell cycle regulators, growth factors, and cell adhesion molecules [11]. Chromosomal abnormalities such as microsatellite instability [12], loss of heterozygosity [13], and point mutations of the p53 gene [14] are often found in
Acknowledgements
This study was partly supported by a grant from the Research Grants Council (RGC) of the Hong Kong Special Administrative Region, China (Project No. HKU 7247/99M), as well as by the Gastric Cancer Research Fund of the Department of Surgery, University of Hong Kong Medical Center. We thank Dr. Z. Li for advice in immunohistochemical results. We are grateful to P.Y. Lee for advice in statistical analysis. We also thank M.X. Zhou, A.O. Chan, and L.L. Shing for technical assistance.
References (29)
Cadherins in cancer: implications for invasion and metastasis
Curr. Opin. Cell Biol.
(1993)- et al.
Structure and interactions of desmosomal and other cadherins
Semin. Cell Biol.
(1992) - et al.
Identification of liver-intestine cadherin in hepatocellular carcinoma—a potential disease marker
Biochem. Biophys. Res. Commun.
(2003) - et al.
High frequency of LOH, MSI and abnormal expression of FHIT in gastric cancer
Eur. J. Cancer
(2002) - et al.
CDX2 regulates liver intestine-cadherin expression in normal and malignant colon epithelium and intestine metaplasia
Gastroenterology
(2002) - et al.
Targeted deficiency or cytosolic truncation of the VE-cadherin gene in mice impairs VEGF-mediated endothelial survival and angiogenesis
Cell
(1999) - et al.
Gene therapy for gastric cancer: problems and prospects
Surg. Oncol.
(2000) - et al.
Cancer statistics
CA Cancer J. Clin.
(1994) - et al.
A causal role for E-cadherin in the transition from adenoma to carcinoma
Nature
(1998) - et al.
Liver-intestine cadherin: molecular cloning and characterization of a novel Ca2+-dependent cell adhesion molecule expressed in liver and intestine
J. Cell Biol.
(1994)